Making your biotech program investor-ready
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Certara2021 年 1 月 21 日
An Introduction to Asset Evaluation for Emerging Biotech Companies
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Certara2021 年 1 月 21 日
Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…
Certara2020 年 12 月 2 日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
Certara2020 年 10 月 20 日
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
有能力根据研究需求进行扩展是成功的关键。Understanding when the…
Certara2020 年 10 月 12 日
Stay on Track and Get Some Sleep: Marketing Application Best Practices
Without careful execution and the ability to navigate unexpected challenges, marketing application submissions are prone…
Certara2020 年 10 月 7 日
Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies
Safety issues account for about a quarter of the attrition in drug projects, and can…
Certara2020 年 10 月 5 日
Payment Pressures in U.S. Specialty: Status quo and outlook for future financing
To allow for the optimal positioning of your product, portfolio, or company, it is critical…
Certara2020 年 9 月 15 日
Exploring Common CDISC ADaM Dataset Conformance Findings
What you need to know when validating your CDISC ADAM datasets During the regulatory review…
Certara2020 年 9 月 3 日
Best Practices for Annotated CRFs
In this webinar, Amy Garrett reviews published guidance from regulatory agencies and provides best practices…
Certara2020 年 7 月 30 日
